Evidence map›Paper›PMID 24777637›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2014

Ubiquitous points of control over regulatory T cells.

Fan Pan, Joseph Barbi

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Fan PanImmunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA, fpan1@jhmi.edu.
Joseph Barbi
Johns Hopkins University · USSidney Kimmel Comprehensive Cancer Center · US

Funding

The Role of EOS in Regulatory T-cell Biology.R01AI089830 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PARDOLL, DREW M. · 2010 to 2014
$2.0M
Metabolic regulation of T cell fate and tumor immunityR01AI099300 · NIAID · JOHNS HOPKINS UNIVERSITY · PI PAN, FAN · 2013 to 2017
$2.0M
NIAID NIH HHS R01 AI089830NIAID NIH HHS R01AI089830NIAID NIH HHS R01 AI099300NIAID NIH HHS R01AI099300
6 · The paper itself

Abstract

Posttranslational modification by ubiquitin tagging is crucial for regulating the stability, activity and cellular localization of many target proteins involved in processes including DNA repair, cell cycle progression, protein quality control, and signal transduction. It has long been appreciated that ubiquitin-mediated events are important for certain signaling pathways leading to leukocyte activation and the stimulation of effector function. Now it is clear that the activities of molecules and pathways central to immune regulation are also modified and controlled by ubiquitin tagging. Among the mechanisms of immune control, regulatory T cells (or Tregs) are themselves particularly sensitive to such regulation. E3 ligases and deubiquitinases both influence Tregs through their effects on the signaling pathways pertinent to these cells or through the direct, posttranslational regulation of Foxp3. In this review, we will summarize and discuss several examples of ubiquitin-mediated control over multiple aspects of Treg biology including the generation, function and phenotypic fidelity of these cells. Fully explored and exploited, these potential opportunities for Treg modulation may lead to novel immunotherapies for both positive and negative fine-tuning of immune restraint.

Indexed as

AnimalsHumansProtein Processing, Post-TranslationalSignal TransductionT-Lymphocytes, RegulatoryUbiquitinUbiquitin-Protein LigasesUbiquitinUbiquitin-Protein Ligases

Identifiers

PMID24777637
PMCPMC4083097
OpenAlexW2037441333

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.